Jeff BrownEditor, The Bleeding Edge, The Near Future Report, Exponential Tech Investor, Day One Investor, and Brownstone Unlimited

Jeff Brown

Jeff Brown is the founder and chief investment analyst for Brownstone Research. Before founding Brownstone Research, Jeff spent 25 years as a high-technology executive. He worked as an executive level for some of the best technology companies in the world, like Qualcomm, NXP Semiconductors, and Juniper Networks.

As an active and successful angel investor in early stage technology companies, he has access to information the public never sees. He is on the front line, in the field, seeing things months, if not years, before the mass market becomes aware.

Jeff has a wide range of technology industry experience. From semiconductors to mobility… to broadcasting and video technology… to technology infrastructure… to IT networking and security… to automotive and even consumer electronics… he’s done it all.

He has built organizations from the ground up and run divisions of companies generating hundreds of millions in revenue a year.

Though he was born, educated, and began his career in America, he spent two decades living and working in international markets, with much of that time spent in Tokyo, Japan. That gives him a unique global perspective on business, investing, and analysis.

Jeff earned his undergraduate degree in aeronautical and astronautical engineering from Purdue University. He also earned his master’s degree in management from the London Business School. Jeff is also an alumnus of Yale University’s School of Management.

In addition to formal degrees, Jeff has professional certificates from MIT, Stanford, UC Berkeley’s School of Law, and the National University of Singapore.

Jeff is an active board member and adviser to several companies and an active angel investor.

Today, Jeff uses his technology, business, finance, and investing expertise to help everyday investors discover companies on the verge of exponential growth.

Jeff Brown’s Research Services

The Bleeding Edge

Learn more

The Near Future Report

Learn more

Exponential Tech Investor

Learn more

Day One Investor

Learn more

Brownstone Unlimited

Learn more

Big Pharma Won’t Stop Biotech’s Next Wave of Cures

This decade will unleash an absolute renaissance of biotechnology, genetic editing, and therapeutic development. And for smart investors, there will be more opportunities to profit for years to come…

Neuralink’s Tech Allows Monkey to Play Video Game With Its Mind

I predicted that Elon Musk’s Neuralink would do some amazing things within the next 18 months. This news exceeded...

How We’ll Position Ourselves for a Post-COVID World

The COVID-19 pandemic may have brought our world to a standstill, but it also brought forward some of the...

GameStop’s Climb Reveals the Pit Falls of Short Selling

GameStop’s surge proved one thing: retail investors finally figured out how to profit from Wall Street’s short selling…

Google Deleted Nearly 100,000 Negative Robinhood Reviews

Can Robinhood repair the damage that it has done to its brand and reputation? In time, yes… but these...

Robinhood Stokes the GameStop Trading Controversy

Last Thursday, we crawled down the rabbit hole of the extraordinary situation around GameStop (GME). Turns out, that was...

SPACs Are Set Up for a Record Year in 2021

Special purpose acquisition corporations – known as SPACs or “blank check” companies – are a huge trend we’re following...